Skip to content
  1. Home
  2. People
  3. Anita Balasubramanian
Anita Balasubramanian
Anita Balasubramanian
Associate — Mergers & Acquisitions and Capital Markets
E: abalasubramanian@velaw.com T: +1.212.237.0062
VCard BIO PDF
Associate — Mergers & Acquisitions and Capital Markets

Anita Balasubramanian

Anita Balasubramanian
New York
T: +1.212.237.0062
F: +1.917.677.8430

The Grace Building
1114 Avenue of the Americas
32nd Floor
New York, New York 10036

E: abalasubramanian@velaw.com
VCard BIO PDF
Anita Balasubramanian

Anita’s principal areas of practice are corporate and securities law, including securities offerings, private equity, mergers and acquisitions and general corporate representation. She is also a member of V&E’s Shareholder Activism Practice, which advises public companies in competitive proxy solicitations, hostile takeover and other unsolicited bids, strategic investor relations, and corporate governance.

The following is a list of representative matters in which Anita has assisted.

Experience Highlights

  • Blackwells Capital in its campaign in opposition to the merger between Monmouth Real Estate Corporation and Equity Commonwealth

  • eHealth, Inc. in defense of the proxy fight by Starboard Value LP and the shareholder activism campaign by Hudson Executive Capital LP

  • Synalloy in the defense of the proxy fight by Privet Fund Management and UPG LLC

  • First United Corporation in the defense of the proxy fights by Driver Management Company

Credentials

  • New York University School of Law, J.D., 2019 (Staff Editor, Journal of Law & Business)
  • Cornell University, B.S., Industrial and Labor Relations, 2016 (Dean’s List)
  • Legal 500 U.S., M&A/Corporate & Commercial: Shareholder Activism: Advice to Boards, 2024
  • New York

News & Insights

Rankings & Awards
The Legal 500 US 2024 (Legalease Ltd.) Recognizes Vinson & Elkins in 44 Practice Categories, 131 Lawyers Recommended
June 12, 2024
Deals & Cases
Daktronics, Inc. Strengthens Financial Position by Securing $100 Million In Capital Commitments
May 11, 2023
Insight
ISS and Glass Lewis Weigh in as Poison Pill Adoptions Surge During COVID-19 Pandemic

Published by CorpGov

Coronavirus: Preparation & Response
April 9, 2020